The study delves into the challenges and developments in ensuring access to essential medicines in Ethiopia. The United Nations has recognized access to essential medicines as a fundamental human right. Many developing countries, including Ethiopia, have adopted strategies to bolster local pharmaceutical production to meet this need. Despite these efforts, local production in Ethiopia currently meets only 15-20% of the national demand, primarily offering a limited range of medicines in conventional dosage forms. The rising prevalence of chronic diseases underscores the urgency for a sustainable supply chain to reduce dependency on imports and enhance access to essential medicines. A comprehensive understanding of the Ethiopian pharmaceutical market is crucial to formulate effective policies and investments. The study employed a literature review, analyzing major databases, policy documents, and performance reports from relevant institutions. The findings highlight the need for strategic interventions, including strengthening local production, to ensure the sustainable availability of essential medicines in the country.
You can submit a specific query to QUAMED experts by clicking on the button below. We will send relevant answers directly to your mailbox.
Submit Query